EXPRES2ION BIOTECH Ownership

5JD Stock  EUR 1.83  0.06  3.39%   
EXPRES2ION BIOTECH holds a total of 37.15 Million outstanding shares. Roughly 98.29 percent of EXPRES2ION BIOTECH outstanding shares are held by general public with 1.71 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as EXPRES2ION BIOTECH in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of EXPRES2ION BIOTECH, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in EXPRES2ION BIOTECH HLDG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

EXPRES2ION Stock Ownership Analysis

The company had not issued any dividends in recent years. EXPRES2ION BIOTECH HLDG had 40:1 split on the 21st of September 2024. ExpreS2ion Biotech Holding AB , through its subsidiary, ExpreS2 ion Biotechnologies ApS, develops a platform technology that enables the production of complex proteins for new vaccines and diagnostics of malaria. ExpreS2ion Biotech Holding AB is based in Horsholm, Denmark. EXPRES2ION BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 17 people. For more info on EXPRES2ION BIOTECH HLDG please contact the company at 45 22 22 10 19 or go to http://www.expres2ionbio.com.

EXPRES2ION BIOTECH Outstanding Bonds

EXPRES2ION BIOTECH issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. EXPRES2ION BIOTECH HLDG uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most EXPRES2ION bonds can be classified according to their maturity, which is the date when EXPRES2ION BIOTECH HLDG has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in EXPRES2ION Stock

EXPRES2ION BIOTECH financial ratios help investors to determine whether EXPRES2ION Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EXPRES2ION with respect to the benefits of owning EXPRES2ION BIOTECH security.